Keywords: SARS-CoV-2; Vaccines.

Similar articles

• In brief: Third dose of mRNA-based COVID-19 vaccines for immunocompromised persons.

  [No authors listed][No authors listed]Med Lett Drugs Ther. 2021 Sep 20;63(1633):145-146.Med Lett Drugs Ther. 2021.PMID:34550960No abstract available.
• Revisiting regulatory framework in India for accelerated vaccine development in pandemics with an evidence-based fast-tracking strategy.

  Dinda AK, Tripathi SK, John B.Dinda AK, et al.Indian J Med Res. 2020 Jul & Aug;152(1 & 2):156-163. doi: 10.4103/ijmr.IJMR_3640_20.Indian J Med Res. 2020.PMID:32952146Free PMC article.No abstract available.
• In brief: Pfizer/BioNTech COVID-19 vaccine authorized for adolescents 12-15 years old.

  [No authors listed][No authors listed]Med Lett Drugs Ther. 2021 May 31;63(1625):81.Med Lett Drugs Ther. 2021.PMID:34101717No abstract available.
• Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine.

  Milane L, Amiji M.Milane L, et al.Drug Deliv Transl Res. 2021 Aug;11(4):1309-1315. doi: 10.1007/s13346-021-00911-y. Epub 2021 Jan 29.Drug Deliv Transl Res. 2021.PMID:33512669Free PMC article.Review.
• FDA authorizes Moderna COVID-19 vaccine.

  [No authors listed][No authors listed]Med Lett Drugs Ther. 2021 Jan 25;63(1616):9-10.Med Lett Drugs Ther. 2021.PMID:33512345Review.No abstract available.

Cited by

• Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection.

  Baldeon Vaca G, Meyer M, Cadete A, Hsiao CJ, Golding A, Jeon A, Jacquinet E, Azcue E, Guan CM, Sanchez-Felix X, Pietzsch CA, Mire CE, Hyde MA, Comeaux ME, Williams JM, Sung JC, Carfi A, Edwards DK, Bukreyev A, Bahl K.Baldeon Vaca G, et al.Sci Adv. 2023 Sep 22;9(38):eadh1655. doi: 10.1126/sciadv.adh1655. Epub 2023 Sep 22.Sci Adv. 2023.PMID:37738334Free PMC article.
• Cationic crosslinked carbon dots-adjuvanted intranasal vaccine induces protective immunity against Omicron-included SARS-CoV-2 variants.

  Lei H, Alu A, Yang J, He X, He C, Ren W, Chen Z, Hong W, Chen L, He X, Yang L, Li J, Wang Z, Wang W, Wei Y, Lu S, Lu G, Song X, Wei X.Lei H, et al.Nat Commun. 2023 May 9;14(1):2678. doi: 10.1038/s41467-023-38066-8.Nat Commun. 2023.PMID:37160882Free PMC article.
• Durable CD8 T Cell Memory against SARS-CoV-2 by Prime/Boost and Multi-Dose Vaccination: Considerations on Inter-Dose Time Intervals.

  Natalini A, Simonetti S, Sher C, D'Oro U, Hayday AC, Di Rosa F.Natalini A, et al.Int J Mol Sci. 2022 Nov 19;23(22):14367. doi: 10.3390/ijms232214367.Int J Mol Sci. 2022.PMID:36430845Free PMC article.Review.
• COVID-19 vaccines and a perspective on Africa.

  Mantovani A, Rescigno M, Forni G, Tognon F, Putoto G, Ictho J, Lochoro P.Mantovani A, et al.Trends Immunol. 2023 Mar;44(3):172-187. doi: 10.1016/j.it.2023.01.005. Epub 2023 Jan 11.Trends Immunol. 2023.PMID:36709083Free PMC article.Review.
• Recent developments in the immunopathology of COVID-19.

  Zhang HP, Sun YL, Wang YF, Yazici D, Azkur D, Ogulur I, Azkur AK, Yang ZW, Chen XX, Zhang AZ, Hu JQ, Liu GH, Akdis M, Akdis CA, Gao YD.Zhang HP, et al.Allergy. 2023 Feb;78(2):369-388. doi: 10.1111/all.15593. Epub 2022 Dec 5.Allergy. 2023.PMID:36420736Free PMC article.Review.

Publication types

• News

MeSH terms

• Administration, Intranasal*
• COVID-19 Vaccines* / administration & dosage
• COVID-19* / prevention & control
• China / epidemiology
• Drug Approval*
• Humans
• India / epidemiology

Substances

• COVID-19 Vaccines

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal